Deerfield Management Company, L.P.

All holdings · as of Mar 31, 2026

Company	Class	Value	Shares	% of portfolio
BROOKDALE SR LIVING INC	—	$505.44M	306,885,000	7.5%
Cogent Biosciences, Inc.	—	$348.10M	9,043,903	5.2%
Praxis Precision Medicines, Inc.	—	$310.38M	963,351	4.6%
Viatris Inc	—	$272.99M	20,206,170	4.1%
United Therapeutics Corp	—	$270.99M	457,000	4.0%
Revolution Medicines, Inc.	—	$223.38M	2,297,000	3.3%
MIRUM PHARMACEUTICALS INC	—	$209.44M	70,000,000	3.1%
ARROWHEAD PHARMACEUTICALS IN	—	$207.18M	200,000,000	3.1%
Celcuity Inc.CELC	Common Stock	$195.64M	1,714,000	2.9%
Centene Corp	—	$193.73M	5,917,091	2.9%
Larimar Therapeutics, Inc.	—	$160.23M	35,606,974	2.4%
Brookdale Senior Living Inc.	—	$159.19M	11,637,032	2.4%
Vera Therapeutics, Inc.	—	$149.74M	3,722,100	2.2%
IONIS PHARMACEUTICALS INC	—	$148.65M	1,979,669	2.2%
BIOCRYST PHARMACEUTICALS INC	—	$143.16M	15,038,000	2.1%
Inspire Medical Systems, Inc.	—	$139.43M	2,703,238	2.1%
LEGEND BIOTECH CORPLEGN	ADR	$139.07M	7,687,638	2.1%
AdaptHealth Corp.	—	$136.58M	11,477,730	2.0%
NEWAMSTERDAM PHARMA COMPANY	—	$136.52M	4,264,789	2.0%
Acadia Healthcare Company, Inc.	—	$105.72M	4,520,000	1.6%
ARROWHEAD PHARMACEUTICALS, INC.	—	$98.65M	1,573,297	1.5%
CATALYST PHARMACEUTICALS, INC.	—	$97.64M	3,943,600	1.5%
Indivior Pharmaceuticals, Inc.	—	$94.42M	3,097,790	1.4%
Xenon Pharmaceuticals Inc.	—	$93.95M	1,615,696	1.4%
IONIS PHARMACEUTICALS INC	—	$90.61M	60,000,000	1.4%
Pharvaris N.V.	—	$88.31M	3,126,042	1.3%
Syndax Pharmaceuticals Inc	—	$88.30M	3,779,900	1.3%
Tango Therapeutics, Inc.	—	$86.75M	4,146,813	1.3%
ALIGNMENT HEALTHCARE INC	—	$85.86M	61,000,000	1.3%
Dianthus Therapeutics, Inc.	—	$85.58M	1,019,813	1.3%
PFIZER INC	—	$85.36M	3,040,000	1.3%
NEUROCRINE BIOSCIENCES INC	—	$80.36M	610,000	1.2%
Day One Biopharmaceuticals, Inc.	—	$79.82M	3,723,131	1.2%
Savara IncSVRA	Common Stock	$74.09M	13,569,000	1.1%
ZENAS BIOPHARMA INC	—	$67.25M	65,000,000	1.0%
Enhabit, Inc.	—	$66.90M	4,747,746	1.0%
NEOGENOMICS INC	—	$66.65M	72,689,000	1.0%
GENMAB A/S	—	$66.06M	2,462,000	1.0%
BIO-RAD LABORATORIES, INC.	—	$63.02M	226,070	0.9%
Lantheus Holdings, Inc.	—	$62.80M	827,999	0.9%
ARS Pharmaceuticals, Inc.	—	$60.26M	7,503,812	0.9%
Stoke Therapeutics, Inc.	—	$59.37M	1,823,500	0.9%
Envista Holdings Corp	—	$56.07M	2,210,100	0.8%
IDEAYA BIOSCIENCES, INC.	—	$50.98M	1,530,008	0.8%
BELITE BIO, INCBLTE	ADR	$48.47M	304,013	0.7%
BioMarin Pharmaceutical Inc	—	$48.10M	851,556	0.7%
Kymera Therapeutics, Inc.	—	$46.74M	561,170	0.7%
Certara, Inc.	—	$44.51M	7,808,605	0.7%
BridgeBio Oncology Therapeutics, Inc.BBOT	Common Stock	$43.72M	4,885,446	0.7%
Disc Medicine, Inc.IRON	Common Stock	$42.01M	657,000	0.6%